Library Header Image
LSE Research Online LSE Library Services

Pricing pharmaceuticals: value based pricing in what sense?

McGuire, Alistair, Raikou, Maria and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2008) Pricing pharmaceuticals: value based pricing in what sense? Eurohealth, 14 (2). pp. 3-6. ISSN 1356-1030

Full text not available from this repository.


Reimbursement of pharmaceuticals ought to provide both incentives for and reward innovation, as well as set a price which reflects the market value of the product. In other words reimbursement must reward both dynamic and static efficiency in the pharmaceutical sector. Within the UK a debate has emerged concerning whether the Pharmaceutical Pricing and Reimbursement Scheme, a profits based regulatory scheme, should be replaced with a value based pricing scheme. This article defines these competing reimbursement schemes and outlines their relative costs and benefits.

Item Type: Article
Official URL:
Additional Information: © 2008 LSE Health
Divisions: European Institute
Social Policy
LSE Health
Subjects: R Medicine > RA Public aspects of medicine
Date Deposited: 15 Feb 2011 15:37
Last Modified: 16 May 2024 00:47

Actions (login required)

View Item View Item